Cargando…
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570680/ https://www.ncbi.nlm.nih.gov/pubmed/36234971 http://dx.doi.org/10.3390/molecules27196430 |
_version_ | 1784810170513096704 |
---|---|
author | Jacob, Binu Vogelaar, Alicia Cadenas, Enrique Camarero, Julio A. |
author_facet | Jacob, Binu Vogelaar, Alicia Cadenas, Enrique Camarero, Julio A. |
author_sort | Jacob, Binu |
collection | PubMed |
description | This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides. |
format | Online Article Text |
id | pubmed-9570680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95706802022-10-17 Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development Jacob, Binu Vogelaar, Alicia Cadenas, Enrique Camarero, Julio A. Molecules Review This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides. MDPI 2022-09-29 /pmc/articles/PMC9570680/ /pubmed/36234971 http://dx.doi.org/10.3390/molecules27196430 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jacob, Binu Vogelaar, Alicia Cadenas, Enrique Camarero, Julio A. Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title | Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title_full | Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title_fullStr | Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title_full_unstemmed | Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title_short | Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development |
title_sort | using the cyclotide scaffold for targeting biomolecular interactions in drug development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570680/ https://www.ncbi.nlm.nih.gov/pubmed/36234971 http://dx.doi.org/10.3390/molecules27196430 |
work_keys_str_mv | AT jacobbinu usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment AT vogelaaralicia usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment AT cadenasenrique usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment AT camarerojulioa usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment |